Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold …
Over the last 12 months, insiders at Enovis Corporation have bought $0 and sold $0 worth of Enovis Corporation stock.
On average, over the past 5 years, insiders at Enovis Corporation have bought $5.99M and sold $16.08M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 62,500 shares for transaction amount of $2.9M was made by RALES MITCHELL P (director) on 2021‑08‑04.
2023-08-07 | Sale | Principal Accounting Officer | 174 0.0003% | $59.18 | $10,297 | -8.54% | ||
2023-07-20 | Sale | Principal Accounting Officer | 67 0.0001% | $65.32 | $4,376 | -15.92% | ||
2023-06-02 | Sale | SVP, Chief Financial Officer | 645 0.0011% | $54.17 | $34,940 | -0.02% | ||
2023-05-08 | Sale | director | 1,396 0.0026% | $57.18 | $79,823 | -1.00% | ||
2023-04-03 | Sale | Pres. & COO | 695 0.0013% | $53.54 | $37,210 | +5.69% | ||
2023-03-20 | Sale | SVP, Chief Financial Officer | 600 0.0011% | $51.84 | $31,104 | +9.35% | ||
2023-03-16 | Sale | director | 2,793 0.005% | $52.13 | $145,585 | +5.33% | ||
2023-03-06 | Sale | President & CEO | 6,743 0.0125% | $57.69 | $389,004 | -2.10% | ||
2023-03-06 | Sale | EVP, Strategy & Business Dev. | 1,898 0.0035% | $57.69 | $109,496 | -2.10% | ||
2023-03-06 | Sale | Pres. & COO | 2,102 0.0039% | $57.69 | $121,264 | -2.10% | ||
2023-03-06 | Sale | SVP, Chief HR Officer | 745 0.0014% | $57.69 | $42,979 | -2.10% | ||
2023-03-06 | Sale | SVP, General Counsel | 1,092 0.002% | $57.69 | $62,997 | -2.10% | ||
2023-02-27 | Sale | President & CEO | 18,917 0.0342% | $56.21 | $1.06M | -2.39% | ||
2023-02-27 | Sale | EVP, Strategy & Business Dev. | 5,716 0.0103% | $56.08 | $320,553 | -2.39% | ||
2023-02-27 | Sale | Pres. & COO | 8,156 0.0147% | $56.07 | $457,307 | -2.39% | ||
2023-02-27 | Sale | SVP, Chief HR Officer | 1,963 0.0035% | $56.09 | $110,105 | -2.39% | ||
2023-02-27 | Sale | SVP, General Counsel | 2,491 0.0045% | $56.08 | $139,695 | -2.39% | ||
2023-02-23 | Sale | President & CEO | 3,945 0.0069% | $54.62 | $215,476 | -3.13% | ||
2023-02-23 | Sale | EVP, Strategy & Business Dev. | 1,113 0.0019% | $54.61 | $60,781 | -3.13% | ||
2023-02-23 | Sale | Pres. & COO | 1,232 0.0022% | $54.63 | $67,304 | -3.13% |
RALES STEVEN M | 10 percent owner | 11296361 20.2261% | $46.91 | 1 | 0 | +6.14% |
RALES MITCHELL P | director | 1170201 2.0952% | $46.91 | 14 | 0 | +1.09% |
PRYOR DANIEL A | EVP, Strategy & Business Dev. | 108291 0.1939% | $46.91 | 1 | 19 | <0.0001% |
Shirley Brady | Pres. & COO | 61291 0.1097% | $46.91 | 1 | 7 | +64.66% |
Clark Lynn H | SVP - Global Human Resources | 35662 0.0639% | $46.91 | 1 | 6 | <0.0001% |
T Rowe Price Investment Management Inc | $411.49M | 12.01 | 6.59M | +0.1% | +$432,279.90 | 0.25 | |
BlackRock | $333.16M | 9.73 | 5.33M | +0.07% | +$230,440.50 | 0.01 | |
The Vanguard Group | $305.64M | 8.92 | 4.89M | -0.13% | -$406,861.75 | 0.01 | |
Dimensional Fund Advisors | $199.51M | 5.82 | 3.19M | +0.03% | +$64,510.85 | 0.05 | |
Diamond Hill Investment Group Inc | $152M | 4.44 | 2.43M | -2.87% | -$4.5M | 0.62 |